High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease

Acta Clin Belg. 2011 Nov-Dec;66(6):419-21. doi: 10.2143/ACB.66.6.2062606.

Abstract

We report the case of a 48-year-old Caucasian male positive for HIV-1 who was admitted in our clinic for a fever of unknown origin with weight loss. The CD4 cell count was 99/mm3 and the viral load (VL) was 836500 copies/ml. A first FDG-PET-CT showed abnormal hypermetabolism of multiple lymp nodes, of the bone marrow and of the spleen. Tuberculosis and lymphoma were excluded by a lymph node biopsy and a culture. Six months after the start of a highly active anti-retroviral therapy (HAART) containing lamuvidine, tenofovir, atazanavir boosted by ritonavir, a new FDG-PET-CT showed a complete normalisation of the metabolism in the regions previously described as having a high FDG uptake. The VL was < 37 copies/ml and his CD4 cell count was 399/mm3.

In conclusion: in patients with advanced HIV infections presenting with FUO, high uptake in 18FDG-PET-CT can be the marker of advanced disease reflecting the areas of viral replication.

Publication types

  • Case Reports

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Multimodal Imaging*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals / pharmacokinetics*
  • Tomography, X-Ray Computed*
  • Viral Load

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18